Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

Technetium-99m (99mTc) is used in approximately 85% of diagnostic imaging procedures in nuclear medicine worldwide. Interruptions in the supply of molybdenum (99Mo), which is used to produce 99mTc, ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.

UK MHRA approves trofolastat for diagnostic imaging of prostate cancer in men: United Kingdom Monday, March 31, 2025, 15:00 Hrs [IST] The Medicines and Healthcare products Regulat ...